Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 5 Methyl 3,4 diphenyl Isoxazole. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN106966999A enables high-purity Parecoxib Sodium intermediate production with reduced costs and scalable supply chain reliability for global pharmaceutical manufacturers.
Novel Lewis acid catalyzed route for Parecoxib intermediate. High purity, scalable process replacing expensive silver catalysts with common reagents.
Patent CN111100084A reveals a mild, high-yield synthesis of parecoxib sodium using organic acids. Discover cost-effective manufacturing strategies for this COX-2 inhibitor intermediate.